The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Le taux de mortalité par infections fongiques chez les patients leucémiques peut atteindre 70 %. La prophylaxie antifongique par posaconazole (P) est utilisée durant les épisodes sévères et prolongés de neutropénie suite aux chimiothérapies chez les patients atteints de leucémie aiguë myéloïde (LAM), de syndrome myélodysplasique et en postautogreffe.Nous avons réalisé une étude rétrospective pour...